RXI-109 | CNA Finance

Home Tags RXI-109

Archived Articles

Biotech Stock News (RXII) (GNCA)

Joshua Rodriguez - April 5, 2016

Rxi Pharmaceuticals (NASDAQ:RXII) On Thursday March 31, 2016 Rxi Pharmaceuticals announced that it had received a patent from the United States Patent and Trademark Office...

Archived Articles

Biotech Stock News (RXII) (FPRX) (BMY) (ZFGN)

Joshua Rodriguez - October 20, 2015

Rxi Pharmaceuticals (NASDAQ:RXII) On October 15, 2015 Rxi Pharmaceuticals announced positive phase 2a results for its RXI-109 compound. The trial, known as RXI-109-1402, was comparing...

Archived Articles

Biotech Stock News (RXII) (REGN) (SURG) (VRX) (ACAD)

Joshua Rodriguez - September 8, 2015

Rxi Pharmaceuticals (NASDAQ:RXII) On August 31, 2015 Rxi announced that the 30-day review period for its IND of RXI-109 for scarring of macular degeneration has...

Archived Articles

Biotech Stock News (RXII) (MRK) (BMY) (CNAT) (ICPT)

Joshua Rodriguez - March 31, 2015

Rxi Pharmaceuticals Corp (NASDAQ: RXII) Rxi Pharmaceuticals last week on March 23, 2015 presented at the 73rd Annual Academy of Dermatology in which the company...

Service Stocks

Top Ships (TOPS) Stock: Continues Falling, Here’s What’s Happening

Joshua Rodriguez - November 9, 2017

Top Ships Inc (NASDAQ: TOPS) is having yet another rough start to the trading session today, and for good reason. After exceptional gains early...

How to Sell Your Car if it Doesn’t Run

May 8, 2019

Synergy Pharmaceuticals (SGYP) Stock: Is It In Your Portfolio Yet?

June 1, 2016

Reviews

TradeMiner Review: Is It Worth Your While?

Joshua Rodriguez - February 20, 2019

There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...

Trade Ideas Review: A Deep Dive Into What They Have To...

February 20, 2019

Tradespoon Review: Is The Service Worth Your Money?

February 20, 2019

TradeKing Review 2015 – Read This Before Signing Up

February 20, 2019

Disclaimer- CNA Finance is NOT an Investment Advisor. Our goal is to bring both news and under discovered stocks to the attention of investors to assist in making smart decisions in the market. CNA Finance is a for profit company. That profit is generated through three (3) different types of relationships. First and foremost, we work with pay per click and CPM advertisers on banners. We also have affiliate relationships with various companies where we earn a portion of the sales revenue that we refer. Finally, we may have relationships with some of the companies or IR firms that represent companies mentioned within our works in which we are compensated in cash and or stock for consulting, investor relations, and Press Release services (click here for details). Therefore, while we do everything in our power to provide true, well-researched, and well-thought out opinions, in some instances, a potential conflict of interest may exist. CNA Finance encourages all investors to seek professional advice before making any investment decision.

Tag: RXI-109

Reviews